The following analysts are covering Verrica Pharmaceuticals.
Stacy Ku
Greg Renza
Oren Livnat
Serge Belanger
Glen Santangelo
Kemp Dolliver
Disclaimer: Any opinions, estimates or forecasts regarding
Verricaʼs performance made by the above-referenced
analysts are theirs alone and do not represent opinions,
forecasts or predictions of Verrica or its management, and
no endorsement of such opinions, estimates or forecasts
shall be implied.
VIRTUAL KOL EVENT
Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution for the Treatment of Molluscum